Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA‚ÄĘCER) (Study P04736)

Terminated

Phase 3 Results

Summary of Purpose

The study is designed to determine whether vorapaxar, when added to the existing standard of care (eg, aspirin, clopidogrel) for preventing heart attack and stroke in patients with acute coronary syndrome, will yield additional benefit over the existing standard of care in preventing heart attack and stroke. The... Trial Stopped: The trial was terminated at the request of the Data and Safety Monitoring Board.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 October 2015.

1 Dec 2007 7 Sep 2007 1 Jul 2011 1 Jul 2011 1 Oct 2015 9 May 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available